Artículos Científicos

Editor: NOEL GONZÁLEZ GOTERA Número 184 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 180415 -240415 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 18 y el 24 de abril de 2015. Con “vaccin*” en título: 154 artículos recuperados.

Vacunas meningococo (Neisseria meningitidis)

150. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.

Medini D, Stella M, Wassil J.

Vaccine. 2015 Apr 13. pii: S0264-410X(15)00468-5. doi: 10.1016/j.vaccine.2015.04.015. [Epub ahead of print] Review.

PMID: 25882169 Free Article

Related citations

Select item 25882168

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

108. Chest wall granuloma associated with BCG vaccination presenting as hot abscess in an immunocompetent infant.

Lee HS, Seo KJ, Kim JJ.

J Cardiothorac Surg. 2015 Mar 4;10(1):29. doi: 10.1186/s13019-015-0231-z.

PMID: 25887440 Free PMC Article

Related citations

Select item 25887090 1

137. Gamma-Irradiated Bacille Calmette-Guérin Vaccination Does Not Modulate the Innate Immune Response during Experimental Human Endotoxemia in Adult Males.

Hamers LA, Kox M, Arts RJ, Blok B, Leentjens J, Netea MG, Pickkers P.

J Immunol Res. 2015;2015:261864. doi: 10.1155/2015/261864. Epub 2015 Mar 26.

PMID: 25883989 Free PMC Article

Related citations

Select item 25883262

Vacunas neumococo (Streptococcus pneumoniae)

4. Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development.

Abry MF, Kimenyi KM, Osowo FO, Odhiambo WO, Sewe SO, Kulohoma BW.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print]

PMID: 25902300

Related citations

Select item 25902195

85. Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings.

Ward KF, Trent M, Hull BP, Quinn HE, Dey A, Menzies RI.

BMC Health Serv Res. 2015 Mar 18;15(1):109. doi: 10.1186/s12913-015-0738-y.

PMID: 25889782 Free PMC Article

Related citations

Select item 25889682

101. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV- infected individuals naive to pneumococcal vaccination.

Bhorat AE, Madhi SA, Laudat F, Sundaraiyer V, Gurtman A, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

AIDS. 2015 Apr 17. [Epub ahead of print]

PMID: 25888646

Related citations

Select item 25888637

104. Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance.

Hjálmarsdóttir MÁ, Pétursdóttir B, Erlendsdóttir H, Haraldsson G, Kristinsson KG.

J Antimicrob Chemother. 2015 Apr 17. pii: dkv096. [Epub ahead of print]

PMID: 25888572

Related citations

Select item 25888530

112. Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00458-2. doi: 10.1016/j.vaccine.2015.04.005. [Epub ahead of print]

PMID: 25887086

Related citations

Select item 25887084

119. Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus.

Palmu AA, Kaijalainen T, Jokinen J, Kilpi TM.

Pediatr Infect Dis J. 2015 Apr 16. [Epub ahead of print]

PMID: 25886787

Related citations

Select item 25886704

123. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.

Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O.

BMC Infect Dis. 2015 Feb 14;15(1):61. doi: 10.1186/s12879-015-0787-1.

PMID: 25885764 Free PMC Article

Related citations

Select item 25885641

Vacunas fiebre tifoidea (Salmonella typhi)

2. Live attenuated vaccines for invasive Salmonella infections.

Tennant SM, Levine MM.

Vaccine. 2015 Apr 19. pii: S0264-410X(15)00482-X. doi: 10.1016/j.vaccine.2015.04.029. [Epub ahead of print]

PMID: 25902362

Related citations

Select item 25902360

3. Typhoid fever vaccination strategies.

Date KA, Bentsi-Enchill A, Marks F, Fox K.

Vaccine. 2015 Apr 19. pii: S0264-410X(15)00481-8. doi: 10.1016/j.vaccine.2015.04.028. [Epub ahead of print]

PMID: 25902360

Related citations

Select item 25902300

Vacuna tuberculosis (Mycobacterium tuberculosis)

149. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

Schrager L; Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group.

Vaccine. 2015 Apr 13. pii: S0264-410X(15)00366-7. doi: 10.1016/j.vaccine.2015.03.056. [Epub ahead of print]

PMID: 25882170

Related citations

Select item 25882169

Vacunas, otras

Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium.

Standaert B, Alwan A, Strens D, Raes M, Postma MJ.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] No abstract available.

PMID:

25902371

Related citations

Select item 25902362 2.

Live attenuated vaccines for invasive Salmonella infections.

Tennant SM, Levine MM.

Vaccine. 2015 Apr 19. pii: S0264-410X(15)00482-X. doi: 10.1016/j.vaccine.2015.04.029. [Epub ahead of print]

PMID: 25902362

Related citations

Select item 25902360 3.

Typhoid fever vaccination strategies.

Date KA, Bentsi-Enchill A, Marks F, Fox K.

Vaccine. 2015 Apr 19. pii: S0264-410X(15)00481-8. doi: 10.1016/j.vaccine.2015.04.028. [Epub ahead of print]

PMID: 25902360

Related citations

Select item 25902300 4.

Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development.

Abry MF, Kimenyi KM, Osowo FO, Odhiambo WO, Sewe SO, Kulohoma BW.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print]

PMID: 25902300

Related citations

Select item 25902195 5.

Sycosis Vaccinatum, a Type of Vaccinia Folliculitis.

Braswell MA, Morrissey MW, Ritchie SA, Reddick RL, Kobayashi TT.

JAMA Dermatol. 2015 Apr 22. doi: 10.1001/jamadermatol.2015.0380. [Epub ahead of print] No abstract available.

PMID: 25902195

Related citations

Select item 25902103 6.

[Optic Neuritis after Influenza Vaccination in a Patient after Stem Cell Transplantation].

Jöhr N, Tschopp M, Hollbach N, Gerull S, Halter J, Klenk L, Goldblum D.

Klin Monbl Augenheilkd. 2015 Apr;232(4):484-486. Epub 2015 Apr 22. German. No abstract available.

PMID: 25902103

Related citations

Select item 25901995 7.

Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.

Kondo K, Suzuki K, Washio M, Ohfuji S, Fukushima W, Maeda A, Hirota Y.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print]

PMID: 25901995

Related citations

Select item 25901962 8.

Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis.

Baharia RK, Tandon R, Sharma T, Suthar MK, Das S, Siddiqi MI, Saxena JK, Sundar S, Dube A.

PLoS Negl Trop Dis. 2015 Apr 22;9(4):e0003742. doi: 10.1371/journal.pntd.0003742. eCollection 2015 Apr.

PMID: 25901962

Related citations

Select item 25901737 9.

Correction: Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging.

PLOS Pathogens Staff.

PLoS Pathog. 2015 Apr 22;11(4):e1004861. doi: 10.1371/journal.ppat.1004861. eCollection 2015 Apr.

PMID: 25901737

Related citations

Select item 25901415 10.

A vaccine against Ebola: Problems and opportunities.

Rezza G.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print]

PMID: 25901415

Related citations

Select item 25901343 11.

CMS now publicly reporting hospital flu vaccination rates.

[No authors listed]

Hosp Peer Rev. 2015 Apr;40(4):44-6. No abstract available.

PMID: 25901343

Related citations

Select item 25901285 12.

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics. 7

Sayour EJ, Sanchez-Perez L, Flores C, Mitchell DA.

J Immunother Cancer. 2015 Apr 21;3:13. doi: 10.1186/s40425-015-0058-0. eCollection 2015.

PMID: 25901285

Related citations

Select item 25901173 13.

Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran.

Khatibi M, Rasekh HR.

Iran J Pharm Res. 2015 Spring;14(2):635-49.

PMID: 25901173

Related citations

Select item 25900822 14.

Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic.

Breitbach CJ, Parato K, Burke J, Hwang TH, Bell JC, Kirn DH.

Curr Opin Virol. 2015 Apr 16;13:49-54. doi: 10.1016/j.coviro.2015.03.016. [Epub ahead of print] Review.

PMID: 25900822

Related citations

Select item 25900771 15.

Pediatric orbital cellulitis in the Haemophilus influenzae vaccine era.

Sharma A, Liu ES, Le TD, Adatia FA, Buncic JR, Blaser S, Richardson S.

J AAPOS. 2015 Apr 18. pii: S1091-8531(15)00088-9. doi: 10.1016/j.jaapos.2015.02.004. [Epub ahead of print]

PMID: 25900771

Related citations

Select item 25900433 16.

Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer.

Klosky JL, Russell KM, Simmons JL, Foster RH, Peck K, Green DM, Hudson MM.

Pediatr Blood Cancer. 2015 Apr 20. doi: 10.1002/pbc.25539. [Epub ahead of print]

PMID: 25900433

Related citations

Select item 25900321 17.

Deoxynivalenol in chicken feed alters the vaccinal immune response and clinical biochemical serum parameters but not the intestinal and carcass characteristics.

Ghareeb K, Awad WA, Zebeli Q, Böhm J.

J Anim Physiol Anim Nutr (Berl). 2015 Apr 21. doi: 10.1111/jpn.12328. [Epub ahead of print]

PMID: 25900321

Related citations

Select item 25900134 18.

The Benin experience: How computational modeling can lead to major vaccine policy changes in low and middle income countries.

Lee BY, Schreiber B, Wateska AR, Connor DL, Dicko HM, Jaillard P, Mvundura M, Levin C, Avella M, Haidari LA, Brown ST.

Vaccine. 2015 Apr 18. pii: S0264-410X(15)00475-2. doi: 10.1016/j.vaccine.2015.04.022. [Epub ahead of print]

PMID: 25900134

Related citations

Select item 25900133 19.

Decomposing racial/ethnic disparities in influenza vaccination among the elderly.

Yoo BK, Hasebe T, Szilagyi PG.

Vaccine. 2015 Apr 18. pii: S0264-410X(15)00362-X. doi: 10.1016/j.vaccine.2015.03.054. [Epub ahead of print]

PMID: 25900133

Related citations

Select item 25900132 20.

Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices.

Nowak GJ, Gellin BG, MacDonald NE, Butler R; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 18. pii: S0264-410X(15)00503-4. doi: 10.1016/j.vaccine.2015.04.039. [Epub ahead of print]

PMID: 25900132

Related citations

Select item 25900073 21.

The mechanisms of genetically modified vaccinia viruses for the treatment of cancer.

Jefferson A, Cadet VE, Hielscher A.

Crit Rev Oncol Hematol. 2015 Apr 13. pii: S1040-8428(15)00067-0. doi: 10.1016/j.critrevonc.2015.04.001. [Epub ahead of print] Review.

PMID: 25900073

Related citations

Select item 25899866 22.

A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.

Li ZQ, Shi JX, Fu WD, Zhang Y, Zhang J, Wang Z, Li TS, Chen CF, Guo F, Zhang H.

Mol Immunol. 2015 Apr 16;66(2):276-283. doi: 10.1016/j.molimm.2015.04.004. [Epub ahead of print]

PMID: 25899866

Related citations

Select item 25899178 23.

Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.

Ye J, Wen F, Xu Y, Zhao N, Long L, Sun H, Yang J, Cooley J, Todd Pharr G, Webby R, Wan XF.

Virology. 2015 Apr 16;482:234-243. doi: 10.1016/j.virol.2015.03.051. [Epub ahead of print]

PMID: 25899178

Related citations

Select item 25899139 24.

One-year extended, monthly vaccination prophylaxis combined with hepatitis B immune globulin for hepatitis B after liver transplantation.

Togashi J, Akamastu N, Sugawara Y, Kaneko J, Tamura S, Tanaka T, Arita J, Sakamoto Y, Hasegawa K, Kokudo N.

Hepatol Res. 2015 Apr 20. doi: 10.1111/hepr.12526. [Epub ahead of print]

PMID: 25899139

Related citations

Select item 25898051 25.

Autism occurrence by MMR vaccine status among US children with older siblings with and without autism.

Jain A, Marshall J, Buikema A, Bancroft T, Kelly JP, Newschaffer CJ.

JAMA. 2015 Apr 21;313(15):1534-40. doi: 10.1001/jama.2015.3077.

PMID: 25898051

Related citations

Select item 25898044 26.

Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission.

Fouda GG, Cunningham CK, Permar SR.

JAMA. 2015 Apr 21;313(15):1513-4. doi: 10.1001/jama.2015.1382. No abstract available.

PMID: 25898044

Related citations

Select item 25898032 27.

Why the "no-brainer" HPV vaccine is being ignored.

Rubin R.

JAMA. 2015 Apr 21;313(15):1502-4. doi: 10.1001/jama.2015.2090. No abstract available.

PMID: 25898032

Related citations

Select item 25897811 28.

Therapeutics and vaccines against chikungunya virus.

Ahola T, Courderc T, Ng LF, Hallengärd D, Powers A, Lecuit M, Esteban M, Merits A, Roques P, Liljeström P.

Vector Borne Zoonotic Dis. 2015 Apr;15(4):250-7. doi: 10.1089/vbz.2014.1681.

PMID: 25897811

Related citations

Select item 25897786 29.

Preclinical Testing of a Vaccine Candidate against Tularemia.

Suresh RV, Ma Z, Sunagar R, Bhatty V, Banik S, Catlett SV, Gosselin EJ, Malik M, Bakshi CS.

PLoS One. 2015 Apr 21;10(4):e0124326. doi: 10.1371/journal.pone.0124326. eCollection 2015.

PMID: 25897786 Free Article

Related citations

Select item 25897604 30.

Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.

Fusco WG, Choudhary NR, Stewart SM, Alam SM, Sempowski GD, Elkins C, Leduc I.

Monoclon Antib Immunodiagn Immunother. 2015 Apr;34(2):73-82. doi: 10.1089/mab.2014.0054.

PMID: 25897604

Related citations

Select item 25897220 31.

Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.

Yong CY, Yeap SK, Ho KL, Omar AR, Tan WS.

Int J Nanomedicine. 2015 Apr 2;10:2751-63. doi: 10.2147/IJN.S77405. eCollection 2015.

PMID: 25897220 Free Article

Related citations

Select item 25896687 32.

Treatment with Smallpox Antiviral Tecovirimat (ST-246®) alone or in Combination with ACAM2000® Vaccination is Effective as a Post-Symptomatic Therapy for Monkeypox Virus Infection.

Berhanu A, Prigge JT, Silvera PM, Honeychurch KM, Hruby DE, Grosenbach DW.

Antimicrob Agents Chemother. 2015 Apr 20. pii: AAC.00208-15. [Epub ahead of print]

PMID: 25896687

Related citations

Select item 25896446 33.

Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.

Patil HP, Murugappan S, Vries-Idema J, Meijerhof T, Haan A, Frijlink HW, Wilschut J, Hinrichs WL, Huckriede A.

Eur J Pharm Biopharm. 2015 Apr 17. pii: S0939-6411(15)00170-8. doi: 10.1016/j.ejpb.2015.04.004. [Epub ahead of print]

PMID: 25896446

Related citations

Select item 25896385 34.

Strategies intended to address vaccine hesitancy: Review of published reviews.

Dubé E, Gagnon D, MacDonald NE; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00505-8. doi: 10.1016/j.vaccine.2015.04.041. [Epub ahead of print]

PMID: 25896385 Free Article

Related citations

Select item 25896384 35.

Measuring vaccine hesitancy: The development of a survey tool.

Larson HJ, Jarrett C, Schulz W, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00501-0. doi: 10.1016/j.vaccine.2015.04.037. [Epub ahead of print]

PMID: 25896384 Free Article

Related citations

Select item 25896383 36.

Vaccine hesitancy: Definition, scope and determinants.

MacDonald NE; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00500-9. doi: 10.1016/j.vaccine.2015.04.036. [Epub ahead of print]

PMID: 25896383 Free Article

Related citations

Select item 25896382 37.

Health communication and vaccine hesitancy.

Goldstein S, MacDonald NE, Guirguis S; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00506-X. doi: 10.1016/j.vaccine.2015.04.042. [Epub ahead of print]

PMID: 25896382 Free Article

Related citations

Select item 25896381 38.

Vaccine supplement on vaccine hesitancy.

Hickler B, Guirguis S, Obregon R.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00498-3. doi: 10.1016/j.vaccine.2015.04.034. [Epub ahead of print] No abstract available.

PMID: 25896381 Free Article

Related citations

Select item 25896380 39.

Review of vaccine hesitancy: Rationale, remit and methods.

Schuster M, Eskola J, Duclos P; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00499-5. doi: 10.1016/j.vaccine.2015.04.035. [Epub ahead of print]

PMID:

25896380 Free Article

Related citations

Select item 25896379 40.

Effect of media use on mothers' vaccination of their children in sub-Saharan Africa.

Jung M, Lin L, Viswanath K.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00474-0. doi: 10.1016/j.vaccine.2015.04.021. [Epub ahead of print]

PMID: 25896379

Related citations

Select item 25896378 41.

How to deal with vaccine hesitancy?

Eskola J, Duclos P, Schuster M, MacDonald NE; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00507-1. doi: 10.1016/j.vaccine.2015.04.043. [Epub ahead of print]

PMID: 25896378 Free Article

Related citations

Select item 25896377 42.

Strategies for addressing vaccine hesitancy - A systematic review.

Jarrett C, Wilson R, O'Leary M, Eckersberger E, Larson HJ; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00504-6. doi: 10.1016/j.vaccine.2015.04.040. [Epub ahead of print]

PMID: 25896377 Free Article

Related citations

Select item 25896376 43.

Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP).

Butler R, MacDonald NE; SAGE Working Group on Vaccine Hesitancy.

Vaccine. 2015 Apr 17. pii: S0264-410X(15)00502-2. doi: 10.1016/j.vaccine.2015.04.038. [Epub ahead of print]

PMID: 25896376 Free Article

Related citations

Select item 25895819 44.

Hepatitis: Hepatitis E virus vaccine can provide protection for up to 4.5 years.

[No authors listed]

Nat Rev Gastroenterol Hepatol. 2015 Apr 21. doi: 10.1038/nrgastro.2015.63. [Epub ahead of print] No abstract available.

PMID: 25895819

Related citations

Select item 25895720 45.

Investigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrier.

Zhao Q, Zhang Q, Yue Y, Huang J, Di D, Gao Y, Shao X, Wang S.

Int J Pharm. 2015 Apr 17. pii: S0378-5173(15)00353-1. doi: 10.1016/j.ijpharm.2015.04.045. [Epub ahead of print]

PMID: 25895720

Related citations

Select item 25895529 46.

Sugar and warmth additively decrease pain in newborns getting vaccines.

Harrington JW.

Evid Based Med. 2015 Apr 20. pii: ebmed-2015-110200. doi: 10.1136/ebmed-2015- 110200. [Epub ahead of print] No abstract available.

PMID: 25895529

Related citations

Select item 25895132 47.

Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.

Wang X, Zhao F, He X, Wang J, Zhang Y, Zhang H, Ni Y, Sun J, Wang X, Dou J.

Oncotarget. 2015 Mar 30. [Epub ahead of print]

PMID: 25895132 Free Article

Related citations

Select item 25895053 48.

Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.

Vassilieva EV, Kalluri H, McAllister D, Taherbhai MT, Esser ES, Pewin WP, Pulit- Penaloza JA, Prausnitz MR, Compans RW, Skountzou I.

Drug Deliv Transl Res. 2015 Apr 17. [Epub ahead of print]

PMID: 25895053

Related citations

Select item 25894902 49.

Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.

Shahsavandi S, Ebrahimi MM, Sadeghi K, Mahravani H.

Virol Sin. 2015 Apr 15. [Epub ahead of print]

PMID: 25894902

Related citations

Select item 25894853 50.

Influenza Vaccination as a Novel Trigger of Wells Syndrome in a Child.

Simpson JK, Patalay R, Francis N, Roberts N.

Pediatr Dermatol. 2015 Apr 20. doi: 10.1111/pde.12601. [Epub ahead of print]

PMID: 25894853

Related citations

Select item 25894046 51.

Quadrivalent HPV vaccination was not linked to multiple sclerosis or other demyelinating diseases.

Granwehr B.

Ann Intern Med. 2015 Apr 21;162(8):JC13. doi: 10.7326/ACPJC-2015-162-8-013. No abstract available.

PMID: 25894046

Related citations

Select item 25893808 52.

Development of a potent melanoma vaccine capable of stimulating CD8⁺ T-cells independently of dendritic cells in a mouse model.

Powell KL, Stephens AS, Ralph SJ.

Cancer Immunol Immunother. 2015 Apr 19. [Epub ahead of print]

PMID: 25893808

Related citations

Select item 25893574 53.

Correction: Pharmacokinetic Correlates of the Effects of a Heroin Vaccine on Heroin Self-Administration in Rats.

PLOS ONE Staff.

PLoS One. 2015 Apr 20;10(4):e0126889. doi: 10.1371/journal.pone.0126889. eCollection 2015.

PMID: 25893574 Free Article

Related citations

Select item 25893173 54.

Selecting vaccine strains for H3N2 human influenza A virus.

Suzuki Y.

Meta Gene. 2015 Apr 8;4:64-72. doi: 10.1016/j.mgene.2015.03.003. eCollection 2015 Jun.

PMID: 25893173

Related citations

Select item 25892779 55.

Characteristics of physico-chemical properties of bilberry (Vaccinium myrtillus L.) jams with added herbs.

Korus A, Jaworska G, Bernaś E, Juszczak L.

J Food Sci Technol. 2015 May;52(5):2815-23. doi: 10.1007/s13197-014-1315-9. Epub 2014 Mar 23.

PMID: 25892779

Related citations

Select item 25892718 56.

Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.

Shin D, Park KJ, Lee H, Cho EY, Kim MS, Hwang MH, Kim SI, Ahn DH.

Virus Res. 2015 Apr 16. pii: S0168-1702(15)00139-2. doi: 10.1016/j.virusres.2015.04.005. [Epub ahead of print]

PMID: 25892718

Related citations

Select item 25892508 57.

Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ?

Lecendreux M, Libri V, Jaussent I, Mottez E, Lopez R, Lavault S, Regnault A, Arnulf I, Dauvilliers Y.

J Autoimmun. 2015 Apr 16. pii: S0896-8411(15)00041-4. doi: 10.1016/j.jaut.2015.03.003. [Epub ahead of print]

PMID: 25892508

Related citations

Select item 25892368 58.

Immune responses to oral pcDNA-VP2 vaccine in relation to infectious pancreatic necrosis virus carrier state in rainbow trout Oncorhynchus mykiss.

Ballesteros NA, Rodriguez Saint-Jean S, Perez-Prieto SI.

Vet Immunol Immunopathol. 2015 Apr 8. pii: S0165-2427(15)00079-3. doi: 10.1016/j.vetimm.2015.04.001. [Epub ahead of print]

PMID: 25892368 Free Article

Related citations

Select item 25892233 59.

Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design.

Sharma SK, de Val N, Bale S, Guenaga J, Tran K, Feng Y, Dubrovskaya V, Ward AB, Wyatt RT.

Cell Rep. 2015 Apr 13. pii: S2211-1247(15)00326-5. doi: 10.1016/j.celrep.2015.03.047. [Epub ahead of print]

PMID: 25892233 Free Article

Related citations

Select item 25891956 60.

Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components.

Echeverría-Zudaire LA, Ortigosa-Del Castillo L, Alonso-Lebrero E, Álvarez-García FJ, Cortés-Álvarez N, García-Sánchez N, Martorell-Aragonés A.

Allergol Immunopathol (Madr). 2015 Apr 16. pii: S0301-0546(15)00020-8. doi: 10.1016/j.aller.2015.01.004. [Epub ahead of print] Review.

PMID: 25891956

Related citations

Select item 25891917 61.

Isolation and characterization of a native avirulent strain of Streptococcus suis serotype 2: a perspective for vaccine development.

Yao X, Li M, Wang J, Wang C, Hu D, Zheng F, Pan X, Tan Y, Zhao Y, Hu L, Tang J, Hu F.

Sci Rep. 2015 Apr 20;5:9835. doi: 10.1038/srep09835.

PMID: 25891917

Related citations

Select item 25891647 62.

Combination vaccines against diarrheal diseases.

Venkatesan MM, Van de Verg LL.

Hum Vaccin Immunother. 2015 Apr 18:0. [Epub ahead of print]

PMID: 25891647

Related citations

Select item 25891536 63.

Vaccination of sheep and cattle against haemonchosis.

Bassetto CC, Amarante AF.

J Helminthol. 2015 Apr 20:1-9. [Epub ahead of print] 22

PMID: 25891536

Related citations

Select item 25891485 64.

[Strategies to improve influenza vaccination coverage in Primary Health Care].

Antón F, Richart MJ, Serrano S, Martínez AM, Pruteanu DF.

Semergen. 2015 Apr 16. pii: S1138-3593(15)00112-4. doi: 10.1016/j.semerg.2015.02.014. [Epub ahead of print] Spanish.

PMID: 25891485

Related citations

Select item 25891446 65.

Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal two-dose MMR vaccination in Israel.

Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD.

Hum Vaccin Immunother. 2015 Apr 18:0. [Epub ahead of print]

PMID: 25891446

Related citations

Select item 25891399 66.

Immune overload: Parental attitudes toward combination and single antigen vaccines.

Hulsey E, Bland T.

Vaccine. 2015 Apr 16. pii: S0264-410X(15)00473-9. doi: 10.1016/j.vaccine.2015.04.020. [Epub ahead of print]

PMID: 25891399

Related citations

Select item 25891359 67.

Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.

Pérez Sánchez L, Morera Díaz Y, Bequet-Romero M, Ramses Hernández G, Rodríguez Y, Castro Velazco J, Puente Pérez P, Ayala Avila M, Gavilondo JV.

Hum Vaccin Immunother. 2015 Apr 18:0. [Epub ahead of print]

PMID: 25891359

Related citations

Select item 25891124 68.

Evaluation of commercially available standardized in-clinic dot-ELISA test kits for the semi-quantitative analysis of canine parvovirus IgG antibodies in vaccinated and non- vaccinated dogs in Abeokuta, Nigeria.

Babalola ET, Ijaopo OK, Okonko IO.

J Immunoassay Immunochem. 2015 Apr 18. [Epub ahead of print]

PMID: 25891124

Related citations

Select item 25890821 69.

The effect of a live Neospora caninum tachyzoite vaccine in naturally infected pregnant dairy cows.

Mazuz ML, Fish L, Wolkomirsky R, Leibovich B, Reznikov D, Savitsky I, Golenser J, Shkap V.

Prev Vet Med. 2015 Apr 8. pii: S0167-5877(15)00115-4. doi: 10.1016/j.prevetmed.2015.03.020. [Epub ahead of print]

PMID: 25890821

Related citations

Select item 25890751 70.

Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine.

Huang FY, Huang FR, Chen B, Liu Q, Wang H, Zhou SL, Zhao HG, Huang YH, Lin YY, Tan GH.

Biomaterials. 2015 Jun;53:554-65. doi: 10.1016/j.biomaterials.2015.02.123. Epub 2015 Mar 23.

PMID: 25890751

Related citations

Select item 25890706 71.

A single dose biodegradable vaccine depot that induces persistently high levels of antibody over a year.

Chua BY, Sekiya T, Al Kobaisi M, Short KR, Mainwaring DE, Jackson DC.

Biomaterials. 2015 Jun;53:50-7. doi: 10.1016/j.biomaterials.2015.02.066. Epub 2015 Mar 9.

PMID: 25890706

Related citations

Select item 25890684 72.

Impact of Health Insurance Status on Vaccination Coverage Among Adult Populations.

Lu PJ, O'Halloran A, Williams WW.

Am J Prev Med. 2015 Apr 15. pii: S0749-3797(14)00719-3. doi: 10.1016/j.amepre.2014.12.008. [Epub ahead of print]

PMID: 25890684

Related citations

Select item 25890634 73.

Surveillance of adverse events following vaccination in the French armed forces, 2011- 2012.

Mayet A, Duron S, Meynard JB, Koeck JL, Deparis X, Migliani R.

Public Health. 2015 Apr 15. pii: S0033-3506(15)00111-0. doi: 10.1016/j.puhe.2015.03.003. [Epub ahead of print]

PMID: 25890634

Related citations

Select item 22373530 74.

Avian cell line - Technology for large scale vaccine production.

Kraus B, von Fircks S, Feigl S, Koch SM, Fleischanderl D, Terler K, Dersch-Pourmojib M, Konetschny C, Grillberger L, Reiter M.

BMC Proc. 2011 Nov 22;5 Suppl 8:P52. doi: 10.1186/1753-6561-5-S8-P52. eCollection 2011. No abstract available.

PMID: 22373530 Free Article

Related citations

Select item 22373480 75.

Efficacy of an inactivated and adjuvanted "ZULVAC(®) 8 OVIS" vaccine produced using single-use bioreactors.

Garcia L, Paradell H, Mouriño M, Alberca B, Urniza A, Vila A, Tarrats M, Plana-Durán J.

BMC Proc. 2011 Nov 22;5 Suppl 8:P118. doi: 10.1186/1753-6561-5-S8-P118. eCollection 2011. No abstract available.

PMID: 22373480 Free Article

Related citations

Select item 22373352 76.

Anti-idiotypic antibody Ab2/3H6 mimicking gp41: a potential HIV-1 vaccine?

Kunert R, Mader A.

BMC Proc. 2011 Nov 22;5 Suppl 8:P64. doi: 10.1186/1753-6561-5-S8-P64. eCollection 2011. No abstract available.

PMID: 22373352 Free Article

Related citations

Select item 22373222 77.

Complex medium supplements optimized for the reduction of animal-derived components in vaccine production media.

Babcock JF, Benedict KA, Perlman AL.

BMC Proc. 2011 Nov 22;5 Suppl 8:P24. doi: 10.1186/1753-6561-5-S8-P24. eCollection 2011. No abstract available.

PMID: 22373222 Free Article

Related citations

Select item 22373097 78.

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Jordan I, Sandig V.

BMC Proc. 2011 Nov 22;5 Suppl 8:O1. doi: 10.1186/1753-6561-5-S8-O1. eCollection 2011. No abstract available.

PMID: 22373097 Free Article

Related citations

Select item 22373084 79.

Development of live cultural pandemic influenza vaccine Vector-Flu.

Nechaeva EA, Sen'kina TY, Ryzhikov AB, Radaeva IF, P'yankova OG, Danil'chenko NV, Sviridenko TM, Bogryantzeva MP, Gilina NV, Varaksin NA, Ryabicheva TG, Kiseleva IV, Rudenko LG.

BMC Proc. 2011 Nov 22;5 Suppl 8:P104. doi: 10.1186/1753-6561-5-S8-P104. eCollection 2011. No abstract available.

PMID: 22373084 Free Article

Related citations

Select item 25890386 80.

Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA. 27

Eschner AK, Mugnai K.

Parasit Vectors. 2015 Feb 10;8:92. doi: 10.1186/s13071-015-0676-x.

PMID: 25890386 Free PMC Article

Related citations

Select item 25890350 81.

Vaccination with recombinant paramyosin against the bovine lungworm Dictyocaulus viviparus considerably reduces worm burden and larvae shedding.

Strube C, Haake C, Sager H, Schorderet Weber S, Kaminsky R, Buschbaum S, Joekel D, Schicht S, Kremmer E, Korrell J, Schnieder T, von Samson-Himmelstjerna G.

Parasit Vectors. 2015 Feb 24;8:119. doi: 10.1186/s13071-015-0733-5.

PMID: 25890350 Free PMC Article

Related citations

Select item 25890243 82.

Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.

Li T, Eappen AG, Richman AM, Billingsley PF, Abebe Y, Li M, Padilla D, Rodriguez- Barraquer I, Sim BK, Hoffman SL.

Malar J. 2015 Apr 9;14(1):150. [Epub ahead of print]

PMID: 25890243 Free Article

Related citations

Select item 25890156 83.

Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.

Stanisic DI, Liu XQ, De SL, Batzloff MR, Forbes T, Davis CB, Sekuloski S, Chavchich M, Chung W, Trenholme K, McCarthy JS, Li T, Sim BK, Hoffman SL, Good MF.

Malar J. 2015 Apr 7;14(1):143. doi: 10.1186/s12936-015-0663-x.

PMID: 25890156 Free PMC Article

Related citations

Select item 25889976 84.

Protective immunity against Trichinella spiralis infection induced by TsNd vaccine in mice.

Liu P, Cui J, Liu RD, Wang M, Jiang P, Liu LN, Long SR, Li LG, Zhang SB, Zhang XZ, Wang ZQ.

Parasit Vectors. 2015 Mar 28;8:185. doi: 10.1186/s13071-015-0791-8.

PMID: 25889976 Free PMC Article

Related citations

Select item 25889782 85.

Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings.

Ward KF, Trent M, Hull BP, Quinn HE, Dey A, Menzies RI.

BMC Health Serv Res. 2015 Mar 18;15(1):109. doi: 10.1186/s12913-015-0738-y.

PMID: 25889782 Free PMC Article

Related citations

Select item 25889682 86.

The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.

Muraki Y, Fujita T, Matsuura M, Fuke I, Manabe S, Ishikawa T, Okuno Y, Morita K.

Virol J. 2015 Apr 9;12(1):54. [Epub ahead of print]

PMID: 25889682 Free PMC Article

Related citations

Select item 25889653 87.

Lessons learned from the development of a new methodology to assess missed opportunities for vaccination in Latin America and the Caribbean.

Velandia-González M, Trumbo SP, Díaz-Ortega JL, Bravo-Alcántara P, Danovaro- Holliday MC, Dietz V, Ruiz-Matus C.

BMC Int Health Hum Rights. 2015 Feb 21;15(1):5. doi: 10.1186/s12914-015-0043-1.

PMID: 25889653 Free PMC Article

Related citations

Select item 25889651 88.

Evaluation of biological safety in vitro and immunogenicity in vivo of recombinant Escherichia coli Shiga toxoids as candidate vaccines in cattle.

Kerner K, Bridger PS, Köpf G, Fröhlich J, Barth S, Willems H, Bauerfeind R, Baljer G, Menge C.

Vet Res. 2015 Apr 10;46(1):38. doi: 10.1186/s13567-015-0175-2.

PMID: 25889651 Free PMC Article

Related citations

Select item 25889565 89.

Awareness of human papillomavirus and factors associated with intention to obtain HPV vaccination among Korean youth: quasi experimental study.

Kim HW.

BMC Int Health Hum Rights. 2015 Feb 21;15(1):4. doi: 10.1186/s12914-015-0042-2.

PMID: 25889565 Free PMC Article

Related citations

Select item 25889564 90.

Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection.

Zou Z, Hu Y, Liu Z, Zhong W, Cao H, Chen H, Jin M.

Vet Res. 2015 Apr 16;46(1):42. doi: 10.1186/s13567-015-0174-3.

PMID: 25889564 Free PMC Article

Related citations

Select item 25889495 91.

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage.

Lehmann MH, Price PJ, Brandmüller C, Sutter G.

Virol J. 2015 Feb 12;12(1):21.

PMID: 25889495 Free PMC Article

Related citations

Select item 25889479 92.

Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life.

Pasternak JA, Ng SH, Buchanan RM, Mertins S, Mutwiri GK, Gerdts V, Wilson HL.

BMC Vet Res. 2015 Mar 7;11(1):50. doi: 10.1186/s12917-015-0350-8.

PMID: 25889479 Free PMC Article

Related citations

Select item 25889286 93.

Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes.

Toledo-Machado CM, Bueno LL, Menezes-Souza D, Machado-de-Avila RA, Nguyen C, Granier C, Bartholomeu DC, Chávez-Olórtegui C, Fujiwara RT.

Parasit Vectors. 2015 Feb 28;8:133. doi: 10.1186/s13071-015-0747-z.

PMID: 25889286 Free PMC Article

Related citations

Select item 25889279 94.

Development of vaccine-induced immunity against TRT in turkeys depends remarkably on the level of maternal antibodies and the age of birds on the day of vaccination.

Smialek M, Pestka D, Tykalowski B, Stenzel T, Koncicki A.

BMC Vet Res. 2015 Feb 7;11(1):28. doi: 10.1186/s12917-015-0345-5.

PMID: 25889279 Free PMC Article

Related citations

Select item 25889161 95.

Hepatitis A and B among young persons who inject drugs-Vaccination, past, and present infection.

Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH.

Vaccine. 2015 Apr 15. pii: S0264-410X(15)00472-7. doi: 10.1016/j.vaccine.2015.04.019. [Epub ahead of print]

PMID: 25889161

Related citations

Select item 25889160 96.

One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery.

Haidari LA, Wahl B, Brown ST, Privor-Dumm L, Wallman-Stokes C, Gorham K, Connor DL, Wateska AR, Schreiber B, Dicko H, Jaillard P, Avella M, Lee BY.

Vaccine. 2015 Apr 15. pii: S0264-410X(15)00471-5. doi: 10.1016/j.vaccine.2015.04.018. [Epub ahead of print]

PMID: 25889160

Related citations

Select item 25889134 97.

Cutaneous reactions to vaccinations.

Rosenblatt AE, Stein SL.

Clin Dermatol. 2015 May-Jun;33(3):327-32. doi: 10.1016/j.clindermatol.2014.12.009. Epub 2014 Dec 8.

PMID: 25889134

Related citations

Select item 25888899 98.

PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.

Koinig HC, Talker SC, Stadler M, Ladinig A, Graage R, Ritzmann M, Hennig-Pauka I, Gerner W, Saalmüller A.

Vet Res. 2015 Mar 3;46(1):20. doi: 10.1186/s13567-015-0157-4.

PMID: 25888899 Free PMC Article

Related citations

Select item 25888870 99.

Comparison of the acute phase protein and antioxidant responses in dogs vaccinated against canine monocytic ehrlichiosis and naive-challenged dogs.

Rudoler N, Harrus S, Martinez-Subiela S, Tvarijonaviciute A, van Straten M, Cerón JJ, Baneth G.

Parasit Vectors. 2015 Mar 23;8:175. doi: 10.1186/s13071-015-0798-1.

PMID: 25888870 Free PMC Article

Related citations

Select item 25888727 100.

A quorum sensing-based in vivo expression system and its application in multivalent bacterial vaccine.

Chu T, Ni C, Zhang L, Wang Q, Xiao J, Zhang Y, Liu Q.

Microb Cell Fact. 2015 Mar 18;14(1):37. doi: 10.1186/s12934-015-0213-9.

PMID: 25888727 Free PMC Article

Related citations

Select item 25888646 101.

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV- infected individuals naive to pneumococcal vaccination.

Bhorat AE, Madhi SA, Laudat F, Sundaraiyer V, Gurtman A, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

AIDS. 2015 Apr 17. [Epub ahead of print]

PMID: 25888646

Related citations

Select item 25888637 102.

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.

Khan AN, Kolomeyevskaya N, Singel KL, Grimm MJ, Moysich KB, Daudi S, Grzankowski KS, Lele S, Ylagan L, Webster GA, Abrams SI, Odunsi K, Segal BH.

Oncotarget. 2015 Mar 14. [Epub ahead of print]

PMID: 25888637 Free Article

Related citations

Select item 25888578 103.

Therapeutic peptide vaccine-induced CD8 T cells strongly modulate intratumoral macrophages required for tumor regression. van der Sluis TC, Sluijter M, van Duikeren S, West BL, Melief CJ, Arens R, van der Burg SH, van Hall T.

Cancer Immunol Res. 2015 Apr 17. pii: canimm.0052.2015. [Epub ahead of print]

PMID: 25888578

Related citations

Select item 25888572 104.

Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance.

Hjálmarsdóttir MÁ, Pétursdóttir B, Erlendsdóttir H, Haraldsson G, Kristinsson KG.

J Antimicrob Chemother. 2015 Apr 17. pii: dkv096. [Epub ahead of print]

PMID: 25888572

Related citations

Select item 25888530 105.

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40.

Chen J, Zurawski G, Zurawski S, Wang Z, Akagawa K, Oh S, Hideki U, Fay J, Banchereau J, Song W, Palucka AK.

J Hematol Oncol. 2015 Apr 14;8(1):35. [Epub ahead of print]

PMID: 25888530 Free Article

Related citations

Select item 25887890 106.

Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared.

Lambooij MS, Harmsen IA, Veldwijk J, de Melker H, Mollema L, van Weert YW, de Wit GA.

BMC Med Res Methodol. 2015 Mar 12;15(1):19. doi: 10.1186/s12874-015-0010-5.

PMID: 25887890 Free PMC Article

Related citations

Select item 25887460 107.

Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.

Remschmidt C, Rieck T, Bödeker B, Wichmann O.

BMC Infect Dis. 2015 Mar 20;15(1):137. doi: 10.1186/s12879-015-0882-3.

PMID: 25887460 Free PMC Article

Related citations

Select item 25887440 108.

Chest wall granuloma associated with BCG vaccination presenting as hot abscess in an immunocompetent infant.

Lee HS, Seo KJ, Kim JJ.

J Cardiothorac Surg. 2015 Mar 4;10(1):29. doi: 10.1186/s13019-015-0231-z.

PMID: 25887440 Free PMC Article

Related citations

Select item 25887090 109.

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study.

Mollers M, King AJ, Knol MJ, Scherpenisse M, Meijer CJ, van der Klis FR, de Melker HE.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00469-7. doi: 10.1016/j.vaccine.2015.04.016. [Epub ahead of print]

PMID: 25887090

Related citations

Select item 25887088 110.

Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China.

Wang W, Ma Y, Wang X, Zou H, Zhao F, Wang S, Zhang S, Zhao Y, Marley G, Ma W.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00463-6. doi: 10.1016/j.vaccine.2015.04.010. [Epub ahead of print]

PMID: 25887088

Related citations

Select item 25887087 111.

Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model.

Villarreal DO, Svoronos N, Wise MC, Shedlock DJ, Morrow MP, Conejo-Garcia JR, Weiner DB.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00416-8. doi: 10.1016/j.vaccine.2015.03.086. [Epub ahead of print]

PMID: 25887087

Related citations

Select item 25887086 112.

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00458-2. doi: 10.1016/j.vaccine.2015.04.005. [Epub ahead of print]

PMID: 25887086

Related citations

Select item 25887084 113.

Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data.

Alfelali M, Barasheed O, Tashani M, Azeem MI, Bashir HE, Memish ZA, Heron L, Khandaker G, Booy R, Rashid H; Hajj Research Team.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00459-4. doi: 10.1016/j.vaccine.2015.04.006. [Epub ahead of print]

PMID: 25887084

Related citations

Select item 25887083 114.

Accuracy of administrative claims data to identify dose specific rotavirus vaccination information: Implications for studies of vaccine safety.

Quinlan SC, Lanes S, Holick CN, Mast TC.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00462-4. doi: 10.1016/j.vaccine.2015.04.009. [Epub ahead of print]

PMID: 25887083

Related citations

Select item 25886865 115.

Ubiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine.

Aldarouish M, Wang H, Zhou M, Hu HM, Wang LX.

J Exp Clin Cancer Res. 2015 Apr 16;34(1):34. [Epub ahead of print]

PMID: 25886865 Free Article

Related citations

Select item 25886823 116.

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.

Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM.

BMC Infect Dis. 2015 Feb 18;15(1):66. doi: 10.1186/s12879-015-0791-5.

PMID: 25886823 Free PMC Article

Related citations

Select item 25886800 117.

Ebola vaccine trials: a race against the clock.

Chowell G, Viboud C.

Lancet Infect Dis. 2015 Apr 14. pii: S1473-3099(15)70159-3. doi: 10.1016/S1473- 3099(15)70159-3. [Epub ahead of print] No abstract available.

PMID: 25886800

Related citations

Select item 25886798 118.

Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J.

Lancet Infect Dis. 2015 Apr 14. pii: S1473-3099(15)70139-8. doi: 10.1016/S1473- 3099(15)70139-8. [Epub ahead of print]

PMID: 25886798

Related citations

Select item 25886787 119.

Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus.

Palmu AA, Kaijalainen T, Jokinen J, Kilpi TM.

Pediatr Infect Dis J. 2015 Apr 16. [Epub ahead of print]

PMID: 25886787

Related citations

Select item 25886704 120.

APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine.

Layek B, Lipp L, Singh J.

J Control Release. 2015 Apr 14. pii: S0168-3659(15)00232-1. doi: 10.1016/j.jconrel.2015.04.014. [Epub ahead of print]

PMID: 25886704

Related citations

Select item 25886607 121.

Factors associated with seasonal influenza vaccine uptake among children in Japan.

Shono A, Kondo M.

BMC Infect Dis. 2015 Feb 18;15(1):72. doi: 10.1186/s12879-015-0821-3.

PMID: 25886607 Free PMC Article

Related citations

Select item 25886062 122.

Child survival and BCG vaccination: a community based prospective cohort study in Uganda.

Nankabirwa V, Tumwine JK, Mugaba PM, Tylleskär T, Sommerfelt H; PROMISE- EBF Study Group.

BMC Public Health. 2015 Feb 22;15(1):175. doi: 10.1186/s12889-015-1497-8.

PMID: 25886062 Free PMC Article

Related citations

Select item 25885764 123.

Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.

Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O.

BMC Infect Dis. 2015 Feb 14;15(1):61. doi: 10.1186/s12879-015-0787-1.

PMID: 25885764

Free PMC Article

Related citations

Select item 25885641 124.

Prophylactic and therapeutic DNA vaccines against Chagas disease.

Arce-Fonseca M, Rios-Castro M, Carrillo-Sánchez Sdel C, Martínez-Cruz M, Rodríguez- Morales O.

Parasit Vectors. 2015 Feb 24;8:121. doi: 10.1186/s13071-015-0738-0.

PMID: 25885641 Free PMC Article

Related citations

Select item 25885325 125.

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants.

Ajua A, Lell B, Agnandji ST, Asante KP, Owusu-Agyei S, Mwangoka G, Mpina M, Salim N, Tanner M, Abdulla S, Vekemans J, Jongert E, Lievens M, Cambron P, Ockenhouse CF, Kremsner PG, Mordmüller B.

Malar J. 2015 Feb 13;14(1):72. doi: 10.1186/s12936-015-0605-7.

PMID: 25885325 Free PMC Article

Related citations

Select item 25885282 126.

Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study.

Schurink-Van't Klooster TM, Knol MJ, de Melker HE, van der Sande MA.

BMC Infect Dis. 2015 Mar 24;15(1):148. doi: 10.1186/s12879-015-0898-8.

PMID: 25885282 Free PMC Article

Related citations

Select item 25885063 127.

Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in saxony-anhalt, Germany: a test-negative case-control study.

Helmeke C, Gräfe L, Irmscher HM, Gottschalk C, Karagiannis I, Oppermann H.

PLoS One. 2015 Apr 17;10(4):e0122910. doi: 10.1371/journal.pone.0122910. eCollection 2015.

PMID: 25885063 Free PMC Article

Related citations

Select item 25884906 128.

Medical student's attitude towards influenza vaccination.

Lehmann BA, Ruiter RA, Wicker S, Chapman G, Kok G.

BMC Infect Dis. 2015 Apr 15;15(1):185. [Epub ahead of print]

PMID: 25884906 Free Article

Related citations

Select item 25884801 129.

Immunization with a Live Attenuated H7N9 Influenza Vaccine Protects Mice against Lethal Challenge.

Yang X, Zhao J, Wang C, Duan Y, Zhao Z, Chen R, Zhang L, Xing L, Lai C, Zhang S, Wang X, Yang P.

PLoS One. 2015 Apr 17;10(4):e0123659. doi: 10.1371/journal.pone.0123659. eCollection 2015.

PMID: 25884801 Free PMC Article

Related citations

Select item 25884719 130.

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy.

Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, Sagnelli E, Lamberti M.

BMC Infect Dis. 2015 Mar 25;15(1):149. doi: 10.1186/s12879-015-0874-3.

PMID: 25884719 Free PMC Article

Related citations

Select item 25884628 131.

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses.

Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H.

PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736. doi: 10.1371/journal.pntd.0003736. eCollection 2015 Apr.

PMID: 25884628 Free PMC Article

Related citations

Select item 25884562 132.

Factors influencing H1N1 vaccine behavior among Manitoba Metis in Canada: a qualitative study.

Driedger SM, Maier R, Furgal C, Jardine C.

BMC Public Health. 2015 Feb 12;15(1):128. doi: 10.1186/s12889-015-1482-2.

PMID: 25884562 Free PMC Article

Related citations

Select item 25884522 133.

Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios.

Rubinstein H, Marcu A, Yardley L, Michie S.

BMC Public Health. 2015 Feb 27;15(1):190. doi: 10.1186/s12889-015-1541-8.

PMID: 25884522 Free PMC Article

Related citations

Select item 25884189 134.

Phase 1 study of pandemic h1 DNA vaccine in healthy adults.

Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z, Enama ME, Holman LA, Bailer RT, Pearce MB, Koup RA, Mascola JR, Nabel GJ, Tumpey TM, Schwartz RM, Graham BS, Ledgerwood JE; VRC 308 Study Team.

PLoS One. 2015 Apr 17;10(4):e0123969. doi: 10.1371/journal.pone.0123969. eCollection 2015.

PMID: 25884189 Free PMC Article

Related citations

Select item 25884186 135.

Vaccine storage and cold chain monitoring in the North West region of Cameroon: a cross sectional study.

Yakum MN, Ateudjieu J, Walter EA, Watcho P.

BMC Res Notes. 2015 Apr 14;8(1):145. doi: 10.1186/s13104-015-1109-9.

PMID: 25884186 Free PMC Article

Related citations

Select item 25884004 136.

Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.

Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ.

Open Forum Infect Dis. 2015 Jan 3;2(1):ofu115. doi: 10.1093/ofid/ofu115. eCollection 2015 Jan.

PMID: 25884004 Free PMC Article

Related citations

Select item 25883989 137.

Gamma-Irradiated Bacille Calmette-Guérin Vaccination Does Not Modulate the Innate Immune Response during Experimental Human Endotoxemia in Adult Males.

Hamers LA, Kox M, Arts RJ, Blok B, Leentjens J, Netea MG, Pickkers P.

J Immunol Res. 2015;2015:261864. doi: 10.1155/2015/261864. Epub 2015 Mar 26.

PMID: 25883989 Free PMC Article

Related citations

Select item 25883262 138.

Correction for Fouts et al., Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.

[No authors listed]

Proc Natl Acad Sci U S A. 2015 Apr 16. pii: 201506010. [Epub ahead of print] No abstract available.

PMID: 25883262

Related citations

Select item 25883232 139.

Inhaled measles vaccine is less protective than injected vaccine, study shows.

Mayor S.

BMJ. 2015 Apr 15;350:h2006. doi: 10.1136/bmj.h2006. No abstract available.

PMID: 25883232

Related citations

Select item 25883016 140.

Customizing Vaccines for Melanoma.

[No authors listed]

Cancer Discov. 2015 Apr 16. [Epub ahead of print]

PMID: 25883016

Related citations

Select item 25882914 141.

Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings.

Wang J, Cong Y, Yin R, Feng N, Yang S, Xia X, Xiao Y, Wang W, Liu X, Hu S, Ding C, Yu S, Wang C, Ding Z.

Virus Res. 2015 Apr 13. pii: S0168-1702(15)00140-9. doi: 10.1016/j.virusres.2015.04.006. [Epub ahead of print]

PMID: 25882914

Related citations

Select item 25882872 142.

Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.

Yung CF, Chan SP, Soh S, Tan A, Thoon KC.

J Pediatr. 2015 Apr 13. pii: S0022-3476(15)00339-X. doi: 10.1016/j.jpeds.2015.03.038. [Epub ahead of print]

PMID: 25882872

Related citations

Select item 25882610 143.

The potential of plants for the production and delivery of human papillomavirus vaccines.

Rosales-Mendoza S, Govea-Alonso DO.

Expert Rev Vaccines. 2015 Apr 16:1-11. [Epub ahead of print]

PMID: 25882610

Related citations

Select item 25882478 144.

Construction of a novel porcine circovirus type 2 infectious clone as a basis for the development of a PCV2 iDNA vaccine.

Wang WC, Zeng ZY, Tang Y, Liang HY, Liu Z, Dai ZJ.

J Virol Methods. 2015 Apr 13. pii: S0166-0934(15)00141-X. doi: 10.1016/j.jviromet.2015.04.005. [Epub ahead of print]

PMID: 25882478

Related citations

Select item 25882460 145.

Association between Betapapillomavirus Seropositivity and Keratinocyte Carcinoma- Prospects for Prophylactic Vaccination?

Pfister H.

J Invest Dermatol. 2015 May;135(5):1211-3. doi: 10.1038/jid.2014.523.

PMID: 25882460 Free Article

Related citations

Select item 25882368 146.

Epidemiological study of influenza B in Shanghai during the 2009-2014 seasons: implications for influenza vaccination strategy.

Zhao B, Qin S, Teng Z, Chen J, Yu X, Gao Y, Shen J, Cui X, Zeng M, Zhang X.

Clin Microbiol Infect. 2015 Apr 13. pii: S1198-743X(15)00373-0. doi: 10.1016/j.cmi.2015.03.009. [Epub ahead of print]

PMID: 25882368

Related citations

Select item 25882173 147.

Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.

Xue M, Yu L, Che Y, Lin H, Zeng Y, Fang M, Li T, Ge S, Xia N.

Vaccine. 2015 Apr 2. pii: S0264-410X(15)00387-4. doi: 10.1016/j.vaccine.2015.03.068. [Epub ahead of print]

PMID: 25882173

Related citations

Select item 25882172 148.

Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.

Kovac M, Rathi N, Kuriyakose S, Hardt K, Schwarz TF.

Vaccine. 2015 Apr 14. pii: S0264-410X(15)00443-0. doi: 10.1016/j.vaccine.2015.03.104. [Epub ahead of print]

PMID: 25882172 Free Article

Related citations

Select item 25882170 149.

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

Schrager L; Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group.

Vaccine. 2015 Apr 13. pii: S0264-410X(15)00366-7. doi: 10.1016/j.vaccine.2015.03.056. [Epub ahead of print]

PMID: 25882170

Related citations

Select item 25882169 150.

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.

Medini D, Stella M, Wassil J.

Vaccine. 2015 Apr 13. pii: S0264-410X(15)00468-5. doi: 10.1016/j.vaccine.2015.04.015. [Epub ahead of print] Review.

PMID: 25882169 Free Article

Related citations

Select item 25882168 151.

Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus.

Brinth LS, Pors K, Theibel AC, Mehlsen J.

Vaccine. 2015 Apr 13. pii: S0264-410X(15)00437-5. doi: 10.1016/j.vaccine.2015.03.098. [Epub ahead of print]

PMID: 25882168

Related citations

Select item 25882123 152.

Public Acceptance of Peramivir During the 2009 H1N1 Influenza Pandemic: Implications for Other Drugs or Vaccines Under Emergency Use Authorizations.

Quinn SC, Hilyard K, Castaneda-Angarita N, Freimuth VS.

Disaster Med Public Health Prep. 2015 Apr;9(2):166-74. doi: 10.1017/dmp.2014.156.

PMID: 25882123

Related citations

Select item 25882117 153.

Vaccine effectiveness and coverage against the 2009 pandemic influenza in ghana and Malawi.

Sambala EZ.

Disaster Med Public Health Prep. 2015 Apr;9(2):120. doi: 10.1017/dmp.2015.5. No abstract available.

PMID: 25882117

Related citations

Select item 25877852 154.

Varicella vaccination after fingolimod: A case report.

Berger JR.

Mult Scler Relat Disord. 2013 Oct;2(4):391-4. doi: 10.1016/j.msard.2013.03.002. Epub 2013 Apr 6.

PMID: 25877852

Related citations

AMEDEO - Vaccines Publicaciones (20 - 04 - 2015): 78 artículos nuevos.

Vacunas meningococo (Neisseria meningitidis)

18. The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group A meningococcal conjugate vaccine. J Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25858956&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25858956

30. FROTA AC, Milagres LG, Harrison LH, Ferreira B, et al. Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with HIV in Rio de Janeiro, Brazil. Pediatr Infect Dis J. 2015;34:e113-8. PubMed: www.amedeo.com/p2.php?id=25876102&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25876102

46. MEDINI D, Stella M, Wassil J. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. Vaccine. 2015 Apr 13. pii: S0264-410X(15)00468. PubMed: www.amedeo.com/p2.php?id=25882169&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882169

63. BASTOS RC, de Souza IM, da Silva MN, Silva FP, et al. Brazilian meningococcal C conjugate vaccine: Scaling up studies. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00427. PubMed: www.amedeo.com/p2.php?id=25865466&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865466

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

67. GELDENHUYS HD, Mearns H, Foster J, Saxon E, et al. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guerin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe. Vaccine. 2015 Apr 7. pii: S0264-410X(15)00393. PubMed: www.amedeo.com/p2.php?id=25862299&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25862299

Vacunas neumococo (Streptococcus pneumoniae)

1. BHORAT AE, Madhi SA, Laudat F, Sundaraiyer V, et al. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination. AIDS. 2015. PubMed: www.amedeo.com/p2.php?id=25888646&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25888646

7. CORDONNIER C, Ljungman P, Juergens C, Maertens J, et al. Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged 2 Years and Older: An Open-Label Study. Clin Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25870329&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25870329

29. PALMU AA, Kaijalainen T, Jokinen J, Kilpi TM, et al. Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus. Pediatr Infect Dis J. 2015. PubMed: www.amedeo.com/p2.php?id=25886787&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25886787

40. DECEUNINCK G, De Serres G, Boulianne N, Lefebvre B, et al. Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00458. PubMed: www.amedeo.com/p2.php?id=25887086&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25887086

Vacunas fiebre tifoidea (Salmonella typhi)

8. MOHAN VK, Varanasi V, Singh A, Pasetti MF, et al. Safety and immunogenicity of a Vi polysaccharide-Tetanus Toxoid conjugate vaccine (Typbar-TCVTM) in healthy infants, children and adults in typhoid endemic areas: a multi-center, two-cohort (open-label/double-blind, randomized, controlled), phase III study. Clin Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25870324&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25870324

Vacuna tuberculosis (Mycobacterium tuberculosis)

9. RAFI W, Bhatt K, Gause WC, Salgame P, et al. "Primary and memory immunity to Mycobacterium tuberculosis infection is not compromised in mice with chronic enteric helminth infection" Infect Immun. 2015 Jan 20. pii: IAI.03004. PubMed: www.amedeo.com/p2.php?id=25605766&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25605766

11. PENA JC, Ho W. Monkey Models of Tuberculosis: Lessons Learned. Infect Immun. 2014 Dec 29. pii: IAI.02850. PubMed: www.amedeo.com/p2.php?id=25547788&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25547788

45. SCHRAGER L. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. Vaccine. 2015 Apr 13. pii: S0264-410X(15)00366. PubMed: www.amedeo.com/p2.php?id=25882170&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882170

49. SCHRAGER L. Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: April 9, 2014, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00379. PubMed: www.amedeo.com/p2.php?id=25869894&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869894

54. SCHRAGER L. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings: November 7, 2014, National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00380. PubMed: www.amedeo.com/p2.php?id=25869889&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869889

65. KAUFMANN SH. Aeras-sponsored meeting reports: Aerosol TB vaccines, whole mycobacteria cell TB vaccines, and prevention of sustained Mycobacterium tuberculosis infection. Vaccine. 2015 Apr 8. pii: S0264-410X(15)00444. PubMed: www.amedeo.com/p2.php?id=25863114&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25863114

Vacunas, otras

2. FERNANDEZ LM, Girdler RV, Wright RB, Harper DM, et al.

IIV3 reduced flu in HIV- pregnant women and infants, and in HIV+ pregnant women but not their infants. Ann Intern Med. 2015;162:JC6. PubMed: www.amedeo.com/p2.php?id=25686193&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25686193

3. DU L, Li B, Xu X, Sun B, et al. Adsorption of a porcine reproductive and respiratory syndrome virus DNA vaccine candidate onto biodegradable nanoparticles improves immunogenicity in mice. Arch Virol. 2015. PubMed: www.amedeo.com/p2.php?id=25877819&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25877819

4. MAYOR S. Inhaled measles vaccine is less protective than injected vaccine, study shows. BMJ. 2015;350:h2006. PubMed: www.amedeo.com/p2.php?id=25883232&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25883232

5. MAYOR S. Early trials of Ebola vaccine show immune response. BMJ. 2015;350:h1844. PubMed: www.amedeo.com/p2.php?id=25855620&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25855620

6. BIGGERSTAFF M, Reed C, Swerdlow DL, Gambhir M, et al. Estimating the potential effects of a vaccine program against an emerging influenza pandemic-United States. Clin Infect Dis. 2015;60 Suppl 1:S20-9. PubMed: www.amedeo.com/p2.php?id=25878298&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25878298

PubMed: www.amedeo.com/p2.php?id=25870324&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25870324

10. FRANDOLOSO R, Martinez-Martinez S, Calmettes C, Fegan J, et al. Nonbinding site-directed mutants of transferrin binding protein B exhibit enhanced immunogenicity and protective capabilities. Infect Immun. 2015;83:1030-8. PubMed: www.amedeo.com/p2.php?id=25547790&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25547790

12. SPIERING R, Margry B, Keijzer C, Petzold C, et al. DEC205+ Dendritic Cell-Targeted Tolerogenic Vaccination Promotes Immune Tolerance in Experimental Autoimmune Arthritis. J Immunol. 2015 Apr 10. pii: 1400986. PubMed: www.amedeo.com/p2.php?id=25862815&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25862815

13. NIELSEN CM, White MJ, Bottomley C, Lusa C, et al. Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals. J Immunol. 2015 Apr 8. pii: 1403080. PubMed: www.amedeo.com/p2.php?id=25855356&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25855356

14. BASSI MR, Kongsgaard M, Steffensen MA, Fenger C, et al. CD8+ T cells complement antibodies in protecting against yellow fever virus. J Immunol. 2015;194:1141-53. PubMed: www.amedeo.com/p2.php?id=25539816&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25539816

15. JONES S, Grignard L, Nebie I, Chilongola J, et al. Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45

54 transmission blocking vaccine candidates. J Infect. 2015 Apr 10. pii: S0163-4453(15)00091. PubMed: www.amedeo.com/p2.php?id=25869538&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869538

16. LI W, Ye L, Carrion R Jr, Mohan GS, et al. Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice. J Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25877553&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25877553

17. ECKARD L, Webby R. Neuraminidase: another piece of the influenza vaccine puzzle. J Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25858958&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25858958

19. YUNG CF, Chan SP, Soh S, Tan A, et al. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study. J Pediatr. 2015 Apr 13. pii: S0022-3476(15)00339. PubMed: www.amedeo.com/p2.php?id=25882872&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882872

20. GROSSMAN Z, Grotto I, Tasher D, Stein M, et al. Learning across borders: Advocacy of pediatricians in public health response during a recent wild poliovirus transmission in Israel. J Pediatr. 2014;165:1278-9. PubMed: www.amedeo.com/p2.php?id=25458951&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25458951

21. HULOT SL, Korber B, Giorgi EE, Vandergrift N, et al. Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus and trivalent mosaic Envelope vaccines formulated as a DNA prime, NYVAC and Envelope protein boost. J Virol. 2015 Apr 8. pii: JVI.00383. PubMed: www.amedeo.com/p2.php?id=25855741&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25855741

22. BOYLE KA, Greseth MD, Traktman P. Genetic confirmation that the H5 protein is required for vaccinia virus DNA replication. J Virol. 2015 Apr 8. pii: JVI.00445. PubMed: www.amedeo.com/p2.php?id=25855734&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25855734

23. KIM GN, Wu K, Hong JP, Awamleh Z, et al. Creation of Matrix Protein Gene Variants of Two Serotypes of VSV as Prime-Boost Vaccine Vectors. J Virol. 2015 Apr 8. pii: JVI.00222. PubMed: www.amedeo.com/p2.php?id=25855732&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25855732

24. GROMOWSKI GD, Firestone CY, Whitehead SS. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 that Govern Attenuation of Virulence in Mice. J Virol. 2015 Apr 8. pii: JVI.00219. PubMed: www.amedeo.com/p2.php?id=25855730&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25855730

25. ALIABADI N, Tate JE, Haynes AK, Parashar UD, et al. Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2015;64:337-42. PubMed: www.amedeo.com/p2.php?id=25856253&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25856253

26. ZIPPRICH J, Winter K, Hacker J, Xia D, et al. Measles outbreak--California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep. 2015;64:153-4. PubMed: www.amedeo.com/p2.php?id=25695321&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25695321

27. LOW N, Bavdekar A, Jeyaseelan L, Hirve S, et al. A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med. 2015;372:1519-29. PubMed: www.amedeo.com/p2.php?id=25875257&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25875257

28. GATES B. The next epidemic--lessons from Ebola. N Engl J Med. 2015;372:1381-4. PubMed: www.amedeo.com/p2.php?id=25853741&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25853741

31. VESIKARI T, Van Damme P, Giaquinto C, Dagan R, et al. European Society for Paediatric Infectious Diseases Consensus Recommendations for Rotavirus Vaccination in Europe. Update 2014. Pediatr Infect Dis J. 2015. PubMed: www.amedeo.com/p2.php?id=25860532&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25860532

32. DUNN AC, Black CL, Arnold J, Brodine S, et al. Childhood Vaccination Coverage Rates Among Military Dependents in the United States. Pediatrics. 2015 Apr 13. pii: peds.2014-2101. PubMed: www.amedeo.com/p2.php?id=25869378&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869378

33. VOGEL G. Infectious Diseases. A reassuring snapshot of Ebola. Science. 2015;347:1407. PubMed: www.amedeo.com/p2.php?id=25814564&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25814564

34. KUPFERSCHMIDT K. Infectious diseases. MERS surges again, but pandemic jitters ease. Science. 2015;347:1296-7. PubMed: www.amedeo.com/p2.php?id=25792306&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25792306

35. COLLIER MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, et al. Hepatitis A and B among young persons who inject drugs-Vaccination, past, and present infection. Vaccine. 2015 Apr 15. pii: S0264-410X(15)00472.

PubMed: www.amedeo.com/p2.php?id=25889161&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25889161

36. HAIDARI LA, Wahl B, Brown ST, Privor-Dumm L, et al. One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery. Vaccine. 2015 Apr 15. pii: S0264-410X(15)00471. PubMed: www.amedeo.com/p2.php?id=25889160&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25889160

37. MOLLERS M, King AJ, Knol MJ, Scherpenisse M, et al. Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00469. PubMed: www.amedeo.com/p2.php?id=25887090&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25887090

38. WANG W, Ma Y, Wang X, Zou H, et al. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00463. PubMed: www.amedeo.com/p2.php?id=25887088&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25887088

39. VILLARREAL DO, Svoronos N, Wise MC, Shedlock DJ, et al. Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00416. PubMed: www.amedeo.com/p2.php?id=25887087&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25887087

41. ALFELALI M, Barasheed O, Tashani M, Azeem MI, et al. Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00459. PubMed: www.amedeo.com/p2.php?id=25887084&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25887084

42. QUINLAN SC, Lanes S, Holick CN, Mast TC, et al. Accuracy of administrative claims data to identify dose specific rotavirus vaccination information: Implications for studies of vaccine safety. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00462. PubMed: www.amedeo.com/p2.php?id=25887083&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25887083

43. XUE M, Yu L, Che Y, Lin H, et al. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate. Vaccine. 2015 Apr 2. pii: S0264-410X(15)00387. PubMed: www.amedeo.com/p2.php?id=25882173&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882173

44. KOVAC M, Rathi N, Kuriyakose S, Hardt K, et al. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults. Vaccine. 2015 Apr 13. pii: S0264-410X(15)00443. PubMed: www.amedeo.com/p2.php?id=25882172&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882172

47. BRINTH LS, Pors K, Theibel AC, Mehlsen J, et al. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine. 2015 Apr 13. pii: S0264-410X(15)00437. PubMed: www.amedeo.com/p2.php?id=25882168&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882168

48. GIAMBI C, Del Manso M, D'Ancona F, De Mei B, et al. Actions improving HPV vaccination uptake - Results from a national survey in Italy.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00460. PubMed: www.amedeo.com/p2.php?id=25869895&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869895

50. GOSS MA, Lievano F, Buchanan KM, Seminack MM, et al. Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00467. PubMed: www.amedeo.com/p2.php?id=25869893&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869893

51. JIMENEZ-JORGE S, Pozo F, Larrauri A, de Mateo S, et al. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the last four seasons 2010-2014. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00359. PubMed: www.amedeo.com/p2.php?id=25869892&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869892

52. ORTQVIST A, Bennet R, Hamrin J, Rinder MR, et al. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00464. PubMed: www.amedeo.com/p2.php?id=25869891&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869891

53. FONTANA D, Kratje R, Etcheverrigaray M, Prieto C, et al. Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00418. PubMed: www.amedeo.com/p2.php?id=25869890&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869890

55. BARAK-CORREN Y, Reis BY. Internet activity as a proxy for vaccination compliance. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00439. PubMed: www.amedeo.com/p2.php?id=25869888&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869888

56. DUBOV A, Phung C. Nudges or mandates? The ethics of mandatory flu vaccination. Vaccine. 2015 Apr 10. pii: S0264-410X(15)00356. PubMed: www.amedeo.com/p2.php?id=25869886&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869886

57. PRESCOTT J, DeBuysscher BL, Feldmann F, Gardner DJ, et al. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00419. PubMed: www.amedeo.com/p2.php?id=25865472&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865472

58. FRANZO G, Naylor CJ, Drigo M, Croville G, et al. Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulence. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00422. PubMed: www.amedeo.com/p2.php?id=25865471&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865471

59. CHANG CJ, Sun B, Robertsen B. Adjuvant activity of fish type I interferon shown in a virus DNA vaccination model. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00423. PubMed: www.amedeo.com/p2.php?id=25865470&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865470

60. ZHANG C, Guo L, Jia X, Wang T, et al. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00424. PubMed: www.amedeo.com/p2.php?id=25865469&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865469

61. SCHIJNS VE, Pretto C, Devillers L, Pierre D, et al. First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00425.

PubMed: www.amedeo.com/p2.php?id=25865468&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865468

62. MVUNDURA M, Lorenson K, Chweya A, Kigadye R, et al. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania. Vaccine. 2015 Apr 9. pii: S0264-410X(15)00414. PubMed: www.amedeo.com/p2.php?id=25865467&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25865467

64. ZHANG H, Qian P, Peng B, Shi L, et al. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets. Vaccine. 2015 Apr 8. pii: S0264-410X(15)00420. PubMed: www.amedeo.com/p2.php?id=25863115&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25863115

Share: http://m.amedeo.com/25863114

66. PEREIRA RC, Silva AN, Souza MC, Silva MV, et al. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Vaccine. 2015 Apr 7. pii: S0264-410X(15)00396. PubMed: www.amedeo.com/p2.php?id=25862300&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25862300

68. HAGAN T, Nakaya HI, Subramaniam S, Pulendran B, et al. Systems vaccinology: Enabling rational vaccine design with systems biological approaches. Vaccine. 2015 Apr 6. pii: S0264-410X(15)00391. PubMed: www.amedeo.com/p2.php?id=25858860&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25858860

69. LEGISA DM, Perez Aguirreburualde MS, Gonzalez FN, Marin-Lopez A, et al. An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice. Vaccine. 2015 Apr 6. pii: S0264-410X(15)00386. PubMed: www.amedeo.com/p2.php?id=25858859&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25858859

70. MAERTZDORF J, Kaufmann SH, Weiner J 3rd. Molecular signatures for vaccine development. Vaccine. 2015 Apr 6. pii: S0264-410X(15)00394. PubMed: www.amedeo.com/p2.php?id=25858856&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25858856

71. LI J, Ge J, Ren S, Zhou T, et al. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection. Vaccine. 2015 Apr 6. pii: S0264-410X(15)00398. PubMed: www.amedeo.com/p2.php?id=25858855&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25858855

72. ZHEN Y, Wang N, Gao Z, Ma X, et al. Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination. Vaccine. 2015 Apr 6. pii: S0264-410X(15)00400. PubMed: www.amedeo.com/p2.php?id=25858854&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25858854

73. MINOR PD. Live attenuated vaccines: Historical successes and current challenges. Virology. 2015 Apr 8. pii: S0042-6822(15)00172. PubMed: www.amedeo.com/p2.php?id=25864107&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25864107

74. CONDIT RC, Moussatche N. The vaccinia virus E6 protein influences virion protein localization during virus assembly. Virology. 2015;482:147-156. PubMed: www.amedeo.com/p2.php?id=25863879&s=vac&pm=badc2a9eebb0fad

ABSTRACT available Share: http://m.amedeo.com/25863879

75. LEE Y, Suk Hwang H, Kim M, Lee Y, et al. Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease. Virology. 2014;476C:217-225. PubMed: www.amedeo.com/p2.php?id=25553517&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25553517

76. LEI H, Peng X, Zhao D, Ouyang J, et al. Lactococcus lactis displayed neuraminidase confers cross protective immunity against influenza A viruses in mice. Virology. 2014;476C:189-195. PubMed: www.amedeo.com/p2.php?id=25546254&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25546254

77. WANG J, Cong Y, Yin R, Feng N, et al. Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings. Virus Res. 2015 Apr 13. pii: S0168-1702(15)00140. PubMed: www.amedeo.com/p2.php?id=25882914&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25882914

78. TOMUSANGE K, Yu W, Suhrbier A, Wijesundara D, et al. Engineering human rhinovirus serotype-A1 as a vaccine vector. Virus Res. 2015 Apr 11. pii: S0168-1702(15)00136. PubMed: www.amedeo.com/p2.php?id=25869880&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25869880

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20150413->20150424): 13 patentes recuperadas.

Vacunas, otras

PAT. Title NO.

1 9,013,699 Vaccine testing system

2 9,012,618 Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native

antigenic structures

3 9,012,200 Composition of bacterial strains, bioremediation mixture and use of this composition for the removal of contaminants

from the soil and the method for purifying the soil

contaminants

4 9,012,198 Method for orthopoxvirus production and purification

5 9,011,878 Vaccine strains of Brachyspira hyodysenteriae

6 9,011,874 Compositions, methods and uses for poxvirus elements in

vaccine constructs

7 9,011,870 Bifunctional protein anchors

8 9,011,866 RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and

transfected dendritic cell vaccines

9 9,005,961 Infectious cDNA of an approved vaccine strain of measles

virus, use for immunogenic compositions

10 9,005,925 Infectious cDNA of an approved vaccine strain of measles

virus, use for immunogenic compositions

11 9,005,633 Psoralen-inactivated viral vaccine and method of

preparation

12 9,005,632 Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or

strains

13 9,005,630 Fusion proteins for the treatment of allergic diseases

European Patent Office (EPO)

Acumulado entre el 13 y el 24 de abril 2015: 7 patentes recuperadas

Vacunas, otras

1. PROTOTYPE OF INDIVIDUALIZED THERAPEUTIC ANTI-HCV VACCINE

Inventor: Applicant: Priority SOMINSKA LATVIJAS Publication info: date: IRINA [LV] BIOMEDICINAS CPC: IPC: LV14987 (A) JANSONS PETIJUMU UN 2013- 2015-04-20 JURIS [LV] STUDIJU 09-25 (+4) CENTRS [LV]

2. HUMAN PAPILLOMA VIRUS THERAPEUTIC VACCINE

Applicant: Inventor: TRUSTEES OF Priority NAKAGAWA Publication info: THE IPC: date: MAYUMI [US] CPC: UNIVERSITY WO2015054678 (A2) CHANG A61K48/00 2013- OF ARKANASAS 2015-04-16 BYEONG S 10-13 BOARD OF [US] [US]

3. FAULT DIAGNOSING METHOD BASED ON SIMULATED VACCINE

Inventor: ZHAO Applicant: CPC: Priority Publication info: JINGSONG IPC: date: UNIV G05B17/02 [CN] US2015106655 (A1) TSINGHUA G06F11/1417 G06F11/14 2012- DAI YIYANG 2015-04-16 [CN] G06F2201/85 07-03 [CN] (+2)

4. Cytokine-expressing cellular vaccine combinations

Inventor: CPC: IPC: JOOSS KARIN Priority Applicant: Publication info: [US] A61K2039/505 A61K38/19 date: CRESON ADURO GVAX A61K2039/5156 A61K38/20 EP2859901 (A1) 2003- JENNIFER INC [US] A61K2039/5158 A61K38/21 2015-04-15 04-02 [US] (+12) (+4) (+5)

5. THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO

PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1

Inventor: CPC: TRZONKOWSKI Applicant: Priority IPC: Publication info: PIOTR [PL] A61K2039/5158 date: GDANSKI UNIV MYSLIWIEC A61K2039/55 A61K35/26 EP2859092 (A1) MEDYCZNY 2012- MALGORZATA A61K35/17 C12N5/0783 2015-04-15 [PL] 06-06 [PL] (+3) (+1)

6. HIV VACCINE

Inventor: IPC: Applicant: CPC: Priority SÖRENSEN Publication info: A61K31/00 date: BIRGER [NO] BIONOR A61K2039/55566 A61K31/19 EP2858667 (A1) ÖKVIST MATS IMMUNO AS A61K2300/00 2012- A61K39/00 2015-04-15 [NO] [NO] (+12) 06-06 (+1) (+5)

7. GENETICALLY MODIFIED SCHMALLENBERG VIRUS (SBV) FOR USE AS VACCINE

Inventor: CPC: ELLIOT Applicant: IPC: Priority Publication info: RICHARD M A01K2227/101 date: UNIV A01K67/027 [GB] A01K2227/102 EP2859094 (A1) GLASGOW A61K39/12 2012- BLAKQORI A01K67/027 2015-04-15 [GB] C12N7/00 06-11 GJON [US] (+9) (+3)

TABLAS DE CONTENIDO

Revista Vaccine

Tabla de Contenidos. Volume 33, Supplement 1, Pages A1 –A254 (7 May 2015)

Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-effectiveness Analyses Edited by J.K. Andrus and D.G. Walker The studies published in this supplement feature work conducted by prominent researchers and investigators in the field of vaccine economics, PAHO/WHO Member States, other WHO Member States outside of PAHO that received training from the PAHO ProVac Initiative and other partners that comprise the EPIC (EPI Costing and Financing of Routine Immunization and New Vaccines) group. All this work was made possible by financial support from the Bill and Melinda Gates Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill and Melinda Gates Foundation or the Pan American Health Organization.

Foreword Pages A1 Carissa F. Etienne

Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses Pages A2-A3 Jon Kim Andrus, Damian G. Walker

Commentaries

Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes Pages A4-A5 Stephen Sosler, Judith Kallenberg, Hope L. Johnson

Perspectives on the development and use of economic evidence for immunization decision-making in a developing country Pages A6-A7 Ida Berenice Molina-Aguilera

The ProVac initiative and evolving decision support Pages A8-A10 Colin F.B. Sanderson

A learning experience from price negotiations for vaccines Pages A11-A12 Yot Teerawattananon, Nattha Tritasavit

Original Research

Costs and financing of routine immunization: Approach and selected findings of a multi- country study (EPIC) Original Research Article Pages A13-A20 Logan Brenzel, Darwin Young, Damian G. Walker

Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience Original Research Article Pages A28-A33 Barbara Jauregui, Ana Gabriela Felix Garcia, Cara Bess Janusz, Julia Blau, Aline Munier, Deborah Atherly, Mercy Mvundura, Rana Hajjeh, Benjamin Lopman, Andrew David Clark, Louise Baxter, Raymond Hutubessy, Ciro de Quadros, Jon Kim Andrus

Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana Original Research Article Pages A40-A46 Jean-Bernard Le Gargasson, Frank K. Nyonator, Moses Adibo, Bradford D. Gessner, Anais Colombini

Cost analysis of routine immunisation in Zambia Original Research Article Pages A47-A52 Carl Schutte, Collins Chansa, Edmore Marinda, Teresa A. Guthrie, Stanley Banda, Zipozihle Nombewu, Katlego Motlogelwa, Marita Lervik, Logan Brenzel, Anthony Kinghorn

Examining the cost of delivering routine immunization in Honduras Original Research Article Pages A53-A59 Cara Bess Janusz, Carlos Castaneda-Orjuela, Ida Berenice Molina Aguilera, Ana Gabriela Felix Garcia, Lourdes Mendoza, Iris Yolanda Diaz, Stephen C. Resch

Costs of routine immunization services in Moldova: Findings of a facility-based costing study Original Research Article Pages A60-A65 K. Goguadze, I. Chikovani, C. Gaberi, D. Maceira, M. Uchaneishvili, N. Chkhaidze, G. Gotsadze

Determinants of routine immunization costing in Benin and Ghana in 2011 Original Research Article Pages A66-A71 Cesaire Damien Ahanhanzo, Xiao Xian Huang, Jean-Bernard Le Gargasson, Justin Sossou, Frank Nyonator, Anais Colombini, Bradford D. Gessner

The drivers of facility-based immunization performance and costs. An application to Moldova Original Research Article Pages A72-A78 Daniel Maceira, Ketevan Goguadze, George Gotsadze

Mapping financial flows for immunisation in Uganda 2009/10 and 2010/11: New insights for methodologies and policy Original Research Article Pages A79-A84 Teresa Guthrie, Charlotte Zikusooka, Brendan Kwesiga, Christabel Abewe, Stephen Lagony, Carl Schutte, Edmore Marinda, Kerrin Humphreys, Katlego Motlogelwa, Zipozihle Chuma Nombewu, Logan Brenzel, Anthony Kinghorn

Tracking financial flows for immunization in Honduras Original Research Article Pages A85-A92 Werner Valdes, Cara Bess Janusz, Ida Berenice Molina Aguilera, Lourdes Mendoza, Iris Yolanda Diaz, Stephen Resch

What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries? Original Research Article Pages A93-A98 Logan Brenzel

Costs of vaccine programs across 94 low- and middle-income countries Original Research Article Pages A99-A108 Allison Portnoy, Sachiko Ozawa, Simrun Grewal, Bryan A. Norman, Jayant Rajgopal, Katrin M. Gorham, Leila A. Haidari, Shawn T. Brown, Bruce Y. Lee

Cost-effectiveness of rotavirus vaccination in Kenya and Uganda Original Research Article Pages A109-A118 Charles Sigei, John Odaga, Mercy Mvundura, Yvette Madrid, Andrew David Clark, Kenya ProVac Technical Working Group, Uganda ProVac Technical Working Group

Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country- led analysis Original Research Article Pages A119-A125 Abdou Diop, Deborah Atherly, Alioune Faye, Farba Lamine Sall, Andrew D. Clark, Leon Nadiel, Binetou Yade, Mamadou Ndiaye, Moussa Fafa Cisse, Mamadou Ba

Cost-effectiveness analysis of rotavirus vaccination in Argentina Original Research Article Pages A126-A134 Analia Uruena, Tomas Pippo, Maria Sol Betelu, Federico Virgilio, Laura Hernandez, Norberto Giglio, Angela Gentile, Maximo Diosque, Carla Vizzotti

Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil Original Research Article Pages A135-A142 Hillegonda Maria Dutilh Novaes, Patricia Coelho de Soarez, Gulnar Azevedo Silva, Andreia Ayres, Alexander Itria, Cristina Helena Rama, Ana Marli Christovam Sartori, Andrew D. Clark, Stephen Resch

Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay Original Research Article Pages A143-A153 Martha Pena Kieninger, Edgar Gimenez Caballero, Antonio Arbo Sosa, Carlos Torres Amarilla, Barbara Jauregui, Cara Bess Janusz, Andrew David Clark, Raul Montesano Castellanos

Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru Original Research Article Pages A154-A166 Edward Mezones-Holguin, Carlos Canelo-Aybar, Andrew David Clark, Cara Bess Janusz, Barbara Jauregui, Seimer Escobedo-Palza, Adrian V. Hernandez, Denhiking Vega- Porras, Marco Gonzalez, Fabian Fiestas, Washington Toledo, Fabiana Michel, Victor J. Suarez

Cost-effectiveness of HPV vaccination in Belize Original Research Article Pages A174-A181 Leslie Walwyn, Cara Bess Janusz, Andrew David Clark, Elise Prieto, Eufemia Waight, Natalia Largaespada

Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013 Original Research Article Pages A182-A191 Mohammed Sibak, Ibrahim Moussa, Nasr El-Tantawy, Shaza Badr, Irtaza Chaudhri, Essam Allam, Louise Baxter, Saiyed Abo Freikha, Celine Hoestlandt, Carlos Lara, Rana Hajjeh, Aline Munier

Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran Original Research Article Pages A192-A200 Mehdi Javanbakht, Maziar Moradi-Lakeh, Mohsen Yaghoubi, Abdoulreza Esteghamati, Roxana Mansour Ghanaie, Sussan Mahmoudi, Ahmad-Reza Shamshiri, Seyed Mohsen Zahraei, Louise Baxter, Sareh Shakerian, Irtaza Chaudhri, Jessica A. Fleming, Aline Munier, Hamid R Baradaran

Cost-effectiveness of rotavirus vaccination in Albania Original Research Article Pages A201-A208 Albana Ahmeti, Iria Preza, Artan Simaku, Erida Nelaj, Andrew David Clark, Ana Gabriela Felix Garcia, Carlos Lara, Celine Hoestlandt, Julia Blau, Silvia Bino

Cost-effectiveness of pneumococcal conjugate vaccination in Croatia Original Research Article Pages A209-A218 V. Visekruna Vucina, S. Kurecic Filipovic, N. Koznjak, V. Stamenic, A.D. Clark, B. Mounaud, J. Blau, C. Hoestlandt, B. Kaic

Cost-effectiveness of pneumococcal conjugate vaccination in Georgia Original Research Article Pages A219-A226

T. Komakhidze, C. Hoestlandt, T. Dolakidze, M. Shakhnazarova, R. Chlikadze, N. Kopaleishvili, K. Goginashvili, M. Kherkheulidze, A.D. Clark, J. Blau

Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina Original Research Article Pages A227-A232 C. Vizzotti, T. Pippo, A. Uruena, J. Altuna, G. Palopoli, M.L. Hernandez, M.F. Artola, H. Fernandez, P. Orellano, M.C. Canero-Velasco, M. Ciocca, M. Ramonet, M. Diosque

Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization Original Research Article Pages A233-A239 Mark Jit, Dang Thi Thanh Huyen, Ingrid Friberg, Hoang Van Minh, Pham Huy Tuan Kiet, Neff Walker, Nguyen Van Cuong, Tran Nhu Duong, Kohei Toda, Raymond Hutubessy, Kimberley Fox, Nguyen Tran Hien

Estimating costs of care for meningitis infections in low- and middle-income countries Original Research Article Pages A240-A247 Allison Portnoy, Mark Jit, Jeremy Lauer, Adriaan Blommaert, Sachiko Ozawa, Meghan Stack, Jillian Murray, Raymond Hutubessy

Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis Original Research Article Pages A248-A254 Lucia Helena de Oliveira, Luiz Antonio Bastos Camacho, Evandro Silva Freira Coutinho, Cuauhtemoc Ruiz-Matus, Jose Paulo Gagliardi Leite

